| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,597,078 | 1,646,916 | 2,032,182 | 1,980,783 | | Cost of Revenue |
-
|
-
| (504,925) | 504,925 | | | Gross Profit | 1,597,078 | 1,646,916 | 2,537,107 | 1,475,858 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 315,185 | 301,483 | 869,067 | (137,773) | | Non Recurring | 4,430 | 4,773 | (77,926) | 10,508 | | Others | 627,064 | 366,914 | 586,275 | 470,406 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 650,399 | 973,746 | 1,159,691 | 1,132,717 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 650,399 | 973,746 | 1,159,691 | 1,132,717 | | Interest Expense | 819,459 | 1,026,547 | 1,529,522 | 1,394,533 | | Income Before Tax | (169,060) | (52,801) | (369,831) | (261,816) | | Income Tax Expense | (46,551) | (31,696) | (154,341) | (103,819) | | Minority Interest | (492) |
-
| (527) | (544) | | | | Net Income From Continuing Ops | (123,001) | (21,105) | (216,017) | (158,541) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (123,001) | (21,105) | (216,017) | (158,541) | | Preferred Stock And Other Adjustments | (25,519) | (26,676) | (27,316) | (27,474) | | | Net Income Applicable To Common Shares | ($148,520) | ($47,781) | ($243,333) | ($186,015) |
|
2.03% Nasdaq 0.00%
Income Statement
